Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10358436 Kinase inhibitors and method of treating cancer

Patent 10358436 was granted and assigned to University Health Network on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

University Health Network

Current Assignee

‌

University Health Network

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103584360

Patent Inventor Names

Yong Liu0

Peter Brent Sampson0

Radoslaw Laufer0

Sze-Wan Li0

Bryan T. Forrest0

Heinz W. Pauls0

Louise G. Edwards0

Miklos Feher0

...

Date of Patent

July 23, 2019

Patent Application Number

159021430

Date Filed

February 22, 2018

Patent Citations Received

‌

US Patent 11858915 Polo like kinase 4 inhibitors

‌

US Patent 10919886 Salt and crystal forms of PLK-4 inhibitor

‌

US Patent 11667627 Salt and crystal forms of PLK-4 inhibitor

Patent Primary Examiner

‌

Samantha L Shterengarts

Patent abstract

The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10358436 Kinase inhibitors and method of treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API